Compulsory licensing for expensive medicines

Publikation: Bog/antologi/afhandling/rapportRapportfagfællebedømt

Standard

Compulsory licensing for expensive medicines. / Van Zimmeren, Esther ; Minssen, Timo; Paemen, Liesbet; Van Dyck, Walter; Luyten, Jeroen; Janssens, Rosanne; Barbier, Liese; Simoens, Steven ; Pouppez, Celine (Redaktør); Cleemput, Irina (Redaktør); Vinck, Imgard (Redaktør).

Brussels : Belgian Health Care Knowledge Centre (KCE)., 2022. 200 s.

Publikation: Bog/antologi/afhandling/rapportRapportfagfællebedømt

Harvard

Van Zimmeren, E, Minssen, T, Paemen, L, Van Dyck, W, Luyten, J, Janssens, R, Barbier, L, Simoens, S, Pouppez, C (red.), Cleemput, I (red.) & Vinck, I (red.) 2022, Compulsory licensing for expensive medicines. Belgian Health Care Knowledge Centre (KCE)., Brussels. <https://kce.fgov.be/en/compulsory-licensing-for-expensive-medicines>

APA

Van Zimmeren, E., Minssen, T., Paemen, L., Van Dyck, W., Luyten, J., Janssens, R., Barbier, L., Simoens, S., Pouppez, C. (red.), Cleemput, I. (red.), & Vinck, I. (red.) (2022). Compulsory licensing for expensive medicines. Belgian Health Care Knowledge Centre (KCE). https://kce.fgov.be/en/compulsory-licensing-for-expensive-medicines

Vancouver

Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R o.a. Compulsory licensing for expensive medicines. Brussels: Belgian Health Care Knowledge Centre (KCE)., 2022. 200 s.

Author

Van Zimmeren, Esther ; Minssen, Timo ; Paemen, Liesbet ; Van Dyck, Walter ; Luyten, Jeroen ; Janssens, Rosanne ; Barbier, Liese ; Simoens, Steven ; Pouppez, Celine (Redaktør) ; Cleemput, Irina (Redaktør) ; Vinck, Imgard (Redaktør). / Compulsory licensing for expensive medicines. Brussels : Belgian Health Care Knowledge Centre (KCE)., 2022. 200 s.

Bibtex

@book{a7537cce19a24b8bb9e8f3908a2df83f,
title = "Compulsory licensing for expensive medicines",
abstract = "Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.",
keywords = "Faculty of Law, Patents, Data, compulsory licensing, expensive medicine",
author = "{Van Zimmeren}, Esther and Timo Minssen and Liesbet Paemen and {Van Dyck}, Walter and Jeroen Luyten and Rosanne Janssens and Liese Barbier and Steven Simoens",
editor = "Celine Pouppez and Irina Cleemput and Imgard Vinck",
year = "2022",
month = jun,
day = "14",
language = "English",
publisher = "Belgian Health Care Knowledge Centre (KCE).",

}

RIS

TY - RPRT

T1 - Compulsory licensing for expensive medicines

AU - Van Zimmeren, Esther

AU - Minssen, Timo

AU - Paemen, Liesbet

AU - Van Dyck, Walter

AU - Luyten, Jeroen

AU - Janssens, Rosanne

AU - Barbier, Liese

AU - Simoens, Steven

A2 - Pouppez, Celine

A2 - Cleemput, Irina

A2 - Vinck, Imgard

PY - 2022/6/14

Y1 - 2022/6/14

N2 - Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.

AB - Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.

KW - Faculty of Law

KW - Patents

KW - Data

KW - compulsory licensing

KW - expensive medicine

M3 - Report

BT - Compulsory licensing for expensive medicines

PB - Belgian Health Care Knowledge Centre (KCE).

CY - Brussels

ER -

ID: 310249981